Guselkumab demonstrated strong efficacy in treating moderate to severe scalp psoriasis, especially in individuals with skin of color, achieving nearly 70% complete scalp clearance by week 48. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Significantly more patients treated with Tremfya vs.

October 11, 2022 – A new, creative and innovative, minimally invasive skin-stretching device provides a promising alternative for surgical treatment of large scalp defects, reports a paper in The ...

In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear skin at Week 52 in Phase 3 ...